You're listening to Plenary Session.

Today on Plenary Session, we have two things in store for you.

First, a discussion between myself and our resident Bloodman, Dr. Tom DeLorey, about

and Dexonet Alpha, a new reversal agent for the DOACs.

And Dexanette Alpha was recently published in New England Journal of Medicine Study,

and it's generating rave reviews online.

Some have called it, quote, insult against empiricism, end quote,

profoundly unimpressed, end quote.

Or perhaps my favorite, someone writes that I was chastised for saying, quote, this is not science.

I will refine my terminology and say instead, this is not usable science.

So stay tuned for this riveting discussion.

But Dr. Tom DeLore is here to put things in true perspective.

Next, I have an interview with Dr. John McConnell.

John McConnell is the OHSU leader in health economics.

He runs a center here, and he's a specialist in health services research in health economics,

and he studies Medicaid, and he is going to talk about the fascinating things

that we see across the nation in Medicaid policy. You won't want to miss it.

So stay tuned. But first, a plug. If you like this episode and you like this podcast, go to the iTunes store and give us five stars. It really means a lot. Write a review if you have the time.

If you want to follow us on Twitter,

we're at Plenary underscore session. And if you really want to support this podcast, now there's a

new option. You can go to patreon.com and you can back us, Patreon.com forward slash plenary session.

You can back us at any level that you choose, and supporters will get access to links and

...